Skip to content
MarketScale
‹ Back to Industries

Sciences

The Tools Leading The Science Community to New Discoveries

Many of our technological advances are used first by the scientific community. Nuclear magnetic resonance machines to analyze molecular structures were turned in the MRI machine used in hospitals, for example. 3D printers were used by scientists before they entered industry. The internet was created for scientific usage before becoming more generally available to the…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Troy Camplin · AiAutomationQuantum ComputingScience
Share
The Tools Leading The Science Community to New Discoveries

Key takeaways

01

Many of our technological advances are used first by the scientific community.

02

Nuclear magnetic resonance machines to analyze molecular structures were turned in the MRI machine used in hospitals, for example.

03

3D printers were used by scientists before they entered industry.

Many of our technological advances are used first by the scientific community. Nuclear magnetic resonance machines to analyze molecular structures were turned in the MRI machine used in hospitals, for example. 3D printers were used by scientists before they entered industry. The internet was created for scientific usage before becoming more generally available to the public, especially through the subsequent development of the world wide web.

So, what are scientists using these days?

Artificial Intelligence

One thing scientists are using more and more is artificial intelligence (AI). AI is being used in what is called augmented analytics to better analyze data and to find patterns that may not be as obvious to humans. Human-AI interactions are resulting in new theories and hypotheses to be tested in the lab. It will be interesting to see what happens as people in-turn put the results of those experiments back into the AI for further refinement of those theories and the development of even more testable hypotheses.

The amount of data collected for all things from science to business has entered the zettabyte era (that is sextillion bytes), meaning it is becoming increasingly impossible for humans to deal with it all. Only AI is even remotely capable of handling this amount of data—an amount which is only increasing each and every moment.

Quantum Computers

Machine learning is going to take a quantum leap the moment quantum computers become fully feasible—and that moment is rapidly approaching. Right now, it is well within the realm of scientific research, in no small part because of the problems with cooling such a system, but it is expected that quantum computing will become more widely available in the next several years.

In the meantime, the development of quantum computing itself will provide researchers with more scientific knowledge about quantum physics and how we can use that knowledge to create more powerful computers and AI. After all, we are still working out exactly how quantum computers do their calculations and knowing that will lead to the design of even better quantum computers.

Quantum computers will help scientists fully integrate complex data, better analyze complex systems and processes, and thus help make better pattern predictions for such systems. This will help not only the physical and biological sciences, but also the more complex social and psychological sciences where reductionist methods have proven less than sufficient to help us understand these processes.

Robots

Robotics is another area which will no doubt impact science. The continuing development of more refined movement will allow field scientists to use robots to reach places that might have otherwise been too dangerous for a human, and it will allow scientists in the lab to engage in more precise manipulations of living and physical objects. The development of soft robotics will further open up research possibilities in more difficult-to-reach areas.

Robotic process automation will also help scientists a great deal more. Many lab processes have been automated, but many more can be. This will free scientists up to do more research, to better keep up with the reading and to do more of the mental work of science rather than having to spend quite so much time doing simple repetitive jobs. The more such technology permeates, the more even the small labs at small colleges will be automated, and the more those scientists can contribute.

Technology is transforming science every bit as much as it does business and our personal lives. Usually, the scientists get the first shot at the most recent technological innovations, trying them out and using them to advance our knowledge. It is sometimes hard to imagine what can come out of scientific instruments—who would have expected body imaging from a chemical structure analysis tool? So long as people are free to think and innovate, we will continue to see technological advances emerging out of the lab and into our living rooms.

For the latest news, videos, and podcasts in the Science Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

About the author

TC
Troy Camplin

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

TC
Troy Camplin